ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 59 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,342,000 | -19.0% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,891,000 | -9.6% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,199,000 | -49.0% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $6,278,000 | -45.1% | 11,206 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $11,430,000 | -25.0% | 11,206 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $15,240,000 | -20.0% | 11,206 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $19,050,000 | +37.1% | 11,206 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $13,895,000 | -12.7% | 11,206 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $15,913,000 | +17.4% | 11,206 | 0.0% | 0.01% | +25.0% |
| Q2 2020 | $13,559,000 | +17.5% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $11,542,000 | -39.1% | 11,206 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $18,938,000 | – | 11,206 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,995,760 | $16,129,000 | 1.12% |
| Palo Alto Investors LP | 1,425,439 | $3,834,000 | 0.29% |
| Granahan Investment Management | 1,438,736 | $3,870,000 | 0.14% |
| WealthTrust Axiom LLC | 130,000 | $349,000 | 0.13% |
| SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $344,000 | 0.09% |
| NIPPON LIFE INSURANCE CO | 17,192 | $2,247,000 | 0.06% |
| Joel Isaacson & Co., LLC | 80,660 | $217,000 | 0.05% |
| Cornerstone Capital, Inc. | 47,200 | $127,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 153,769 | $414,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $758,000 | 0.01% |